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A B S T R A C T
Kounis syndrome, which is known as allergic angina and allergic myocardial infarction today, was
described as the coexistence of acute coronary syndrome with allergic reactions in 1991 by Kounis and
Zavras. We report a case of a 79-year-old man with hypertension, hepatocellular carcinoma (HCC), and
no allergic history. He had received transcatheter arterial chemoembolization (TACE) for treatment of
HCC ﬁve times without allergic reactions. At the sixth time of TACE, he presented an anaphylactic
reaction such as systemic erythema and severe arterial hypotension. Simultaneously, he complained of
anterior chest pain and electrocardiogram showed signiﬁcant ST segment elevation in inferior leads,
indicating inferior myocardial infarction. Emergency coronary angiography, however, did not
demonstrate any organic stenoses or occluded lesions of the coronary arteries. We made the diagnosis
of Kounis syndrome associated with TACE. Although Kounis syndrome is a rare condition, physicians
should be aware of possible co-occurrence of anaphylactic reactions and acute coronary syndrome.
<Learning objective: Kounis syndrome refers to acute coronary syndrome associated with allergic or
anaphylactic reactions. Physicians have to be aware and keep Kounis syndrome in mind whenever they
encounter patients with an anaphylactic reaction. And immediate diagnosis and prompt treatment are
needed.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Simultaneous occurrence of acute coronary syndrome and
allergic reactions is known as Kounis Syndrome, which was
described by Kounis and Zavras in 1991 [1]. Although the
pathophysiology of Kounis syndrome is not completely understood,
allergic reaction-induced coronary inﬂammation and vasospasm are
suggested to play a role. Kounis syndrome is caused by various
factors, such as foods, drugs, environmental exposures, and medical
conditions, all of which induce allergic reactions. Allergens cause
mast cell degranulation and several inﬂammatory mediators such as
histamine, tryptase, chymase, neutral proteases, arachidonic acid
products, platelet activating factor, and various cytokines and
chemokines are released. These mediators cause coronary arterial
spasm, plaque rupture, and thrombosis, resulting in acute coronary* Corresponding author at: Department of Cardiology, Harasanshin Hospital,
Taihakumachi 1-8, Hakata-ku, 812-0033 Fukuoka, Japan. Tel.: +81 92 291 3434;
fax: +81 92 291 3266.
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsyndrome. We report a case of Kounis syndrome that was induced by
transcatheter arterial chemoembolization (TACE) for the treatment
of hepatocellular carcinoma (HCC). Two similar cases that we
experienced are also reviewed.
Case report
A 79-year-old man with a history of HCC treatment by TACE
was admitted to our hospital for another TACE. He had been treated
with TACE for ﬁve times before without allergic reactions. His
medical history was unremarkable except for essential hyperten-
sion with medication. There was no history of allergic diseases.
And he had never complained of anterior chest pain suggestive of
angina pectoris. Approximately 30 min after successful TACE with
iopamidol, an iodinated contrast media, and ethylester of
iodinated poppy-seed oil fatty acid injection, he complained of
anterior chest pain and then lost consciousness. His systolic blood
pressure was decreased to 40 mmHg, and his heart rate was
50 beats per minute. His spontaneous breathing stopped. We
assisted his breathing with bag valve mask ventilation. Intrave-
nous infusion of normal saline and dopamine (3.0 mg/min/kg) wass reserved.
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Twelve-lead electrocardiogram showed signiﬁcant ST segment
elevation in II, III, and aVF leads and complete atrioventricular
block with junctional escape rhythm (Fig. 1A), indicating inferior
myocardial infarction. Depression of ST segment in V2 through V4
leads was also observed, which was considered a reciprocal change.
Flushing on his extremities and trunk was recognized. Wheeze and
stridor were not observed. Emergency coronary angiography was
performed after intravenous administration of hydrocortisone
(100 mg), D-chlorpheniramine maleate (5 mg), and epinephrine
(0.1 mg). When we started coronary angiography, ST segment
changes found in the initial electrocardiogram were not observedFig. 1.
Electrocardiogram of the patient on heart attack. Electrocardiogram was taken
segment elevation in II, III, aVF leads and complete atrioventricular block wi
segment when the patient was referred to cardiac catheterization laboratory(Fig. 1B). Angiography of right coronary artery (RCA) revealed no
stenosis or occlusion even without intracoronary administration of
nitroglycerin (Fig. 2A). After administering nitroglycerin to RCA,
marked dilatation of RCA was observed (Fig. 2B and C),
suggesting involvement of coronary spasm. Angiography of left
coronary artery revealed no organic stenosis or occlusion. The
diagnosis of Kounis syndrome associated with TACE was made,
because anaphylactic reactions and acute coronary syndrome
occurred simultaneously. The next day, physical examination
did not reveal any allergic reactions. Laboratory tests of the
blood showed mild leukocytosis (11 330/mL, neutrophil 88%,
eosinophil 0%) and no change in creatine kinase level (214 U/L, when the patient complained of anterior chest pain. Electrocardiogram showed ST
th junctional escape rhythm (A). Electrocardiogram showed normalization of ST
 (B).
Fig. 2.
Coronary angiography of the patient. Angiography of right coronary
artery (RCA) at left anterior oblique (LAO) view revealed no stenosis or
occlusion without intracoronary administration of nitroglycerin (A).
Angiography of RCA after intracoronary administration of nitroglycerin
revealed no stenosis and marked dilatation compared with control
angiography at LAO (B) and at LAO cranial view (C).
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ﬁndings as a previous one before the event. The patient was
discharged 2 days after.
Discussion
Because there is no speciﬁc diagnostic test for Kounis
syndrome, the diagnosis of Kounis syndrome is based on clinical
signs and symptoms that indicate allergic reactions and acute
coronary events [2]. Allergic symptoms typical of anaphylactic
reactions include hypotension, skin rash, dyspnea, and wheezing.
Acute coronary events are recognized by chest pain and
electrocardiogram changes. This case showed skin rash, hypoten-
sion, and ischemic electrocardiogram changes. Therefore, our case
fulﬁlled the clinical criteria of Kounis syndrome.
Coronary angiography plays a central role in the diagnosis of
acute coronary events. Three variants of Kounis syndrome havebeen reported based on the pathophysiology of coronary events
[3]. Type I variant includes patients with normal coronary arteries
and no coronary risk factor, and acute allergic insults induce
coronary artery spasm. Type II variant includes patients with
quiescent coronary artery disease, and acute allergic insults induce
plaque erosion or rapture. Type III variant includes patients with
drug-eluting coronary artery stent implantation, and acute allergic
insults induce stent thrombosis. Although we did not perform
spasm provocation test, an elevation of ST segment in inferior leads
and almost normal coronary angiogram with marked vasocon-
striction at the baseline angiography strongly suggest vasospasm
of the RCA. Therefore, we diagnosed that our case was type I variant
of Kounis syndrome.
Some examinations are helpful to prove simultaneous occur-
rence of cardiac damage and allergic reaction and support the
diagnosis. Laboratory tests such as measurement of serum cardiac
enzymes, tryptase [4], and histamine, eosinophil number and total
IgE level may be helpful [2]. It was reported that histological
analysis of the aspirated thrombi by hematoxylin–eosin and
Giemsa staining showed the presence of eosinophils and mast cells
[5].
Treatment of Kounis syndrome is not established by any
guidelines. Both acute coronary syndrome management and
anaphylaxis management are needed. Epinephrine (recommended
dose 0.01 mg/kg IM, every 5–15 min), H1 and H2 blockers, and
corticosteroid (hydrocortisone 1–2 mg/kg IV) are recommended
for the treatment of anaphylaxis [6]. Giving aspirin and nitroglyc-
erin and percutaneous coronary intervention are indicated for the
management of acute coronary syndrome [7]. However, we have to
take care when administering these drugs. Epinephrine may
induce or exacerbate coronary vasospasm and aggravate cardiac
ischemia. Nitroglycerin that dilates coronary arteries can exacer-
bate hypotension and tachycardia. Fortunately, epinephrine,
hydrocortisone, and D-chlorpheniramine maleate were safely
given and relieved the patient’s symptoms. Electrocardiogram
changes were improved within 20 min after medication without
adverse effects.
The prognosis of Kounis syndrome is generally reported to be
good and no recurrences have been reported. It is advised to avoid
repeat exposure to the allergen. It was difﬁcult to determine the
allergen in this case, because carbocaine which is a local anesthetic,
iopamidol, and lipiodol were administered through a series of
procedures in TACE. Therefore, these agents should be avoided in
the future treatment. Because of the risk of another anaphylactic
shock, we did not attempt another coronary angiography with a
spasm provocation test even after the condition of the patient was
stabilized.
We experienced three patients admitted to our hospital
between January 2008 and July 2014 including the present case
(Case 3), who showed anaphylactic reactions and heart attack
simultaneously (Table 1). All of them showed no organic coronary
artery stenosis on angiography. Although various electrocardio-
gram changes such as ST segment elevation or depression, negative
T wave, QT interval prolongation, and conduction disturbance
were reported in Kounis syndrome [2], it is intriguing that all of our
three cases showed an elevation of ST segment in II, III, and aVF
leads on electrocardiogram. This ﬁnding suggests that RCA may be
prone to be affected by acute allergic insults more than left
coronary artery. A previous review also suggested that RCA seems
to be affected by coronary vasospasm in Kounis syndrome
[2]. However, the mechanism is not speciﬁed.
Although Kounis syndrome is a rare condition, there are
occasional case reports. One of these reports summarized ﬁve cases
of Kounis syndrome [8]. Two out of ﬁve patients showed an ST
segment elevation in anterior leads whereas the other two patients
showed an ST segment elevation in inferior leads. Various allergens
Table 1 Our three cases of possible Kounis syndrome and another ﬁve cases of Kounis syndrome in past reports.
Age Sex Allergic history Cardiovascular
risk factor
Allergen Electrocardiogram Coronary angiography
Case 1 60 Male No Hypertension Wheat ST segment elevation in II, III and aVF Normal
Case 2 69 Male Bronchial
asthma
Hypertension Not determined ST segment elevation in II, III and aVF Normal
Case 3 79 Male No Hypertension Associated with
transcatheter arterial
chemoembolization
ST segment elevation in II, III and aVF Normal
Case I 66 Male Food allergy None Kiwi ST segment depression in V3–6 and
inferior leads
Not performed
Case II 50 Female Bronchial
asthma
None Ibuprofen ST segment elevation in III and aVF Normal
Case III 57 Male No None Ibuprofen ST segment elevation in inferior leads Revealed spontaneous spasm
Case IV 68 Male No None Omeprazole ST segment elevation in anterior leads Revealed coronary artery disease
of left ascending artery
Case V 67 Female Atopy Hypertension Metamizole ST segment elevation in V2–6 Revealed coronary artery disease
of left ascending artery
Cases 1–3 are our cases. Cases I–V are reported in Ref. [8].
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ﬁndings including our experiences suggest that the (possible)
causes that elicit Kounis syndrome and clinical manifestations are
diverse. These ﬁve cases were included in Table 1 for comparison.
In conclusion, we experienced a case of Kounis syndrome that
showed anaphylactic shock and anterior chest pain with ischemic
electrocardiogram changes mimicking ST-segment elevation myo-
cardial infarction. Although Kounis syndrome is a rare condition,
cardiac symptoms and electrocardiogram changes should be
carefully observed in patients with anaphylactic reactions.
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